Join to View Full Profile
Teresa HayesHouston, TX 77008
Phone+1 281-798-9703
Dr. Hayes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Teresa Hayes, MD is an experienced Oncologist from Houston, TX, and treats patients with various conditions including hematologic oncology and solid tumors. She is an alumna of New York University School of Medicine and had both her residency and Fellowship at Baylor College of Medicine. Dr. Hayes currently holds positions at various medical centers such as Wilcox Medical Center and Kona Community Hospital. Besides her clinical work, Dr. Hayes contributes to medical research and has publications in reputable journals. She has also been involved in multiple clinical trials primarily focused on cancer treatment. In 2014, she was acknowledged as a Regional Top Doctor by Castle Connolly.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1988- Baylor College of MedicineResidency, Internal Medicine, 1982 - 1985
New York University School of MedicineClass of 1982
Certifications & Licensure
MT State Medical License 2017 - 2027
AK State Medical License 2017 - 2026
CA State Medical License 2017 - 2026
HI State Medical License 2018 - 2026
MD State Medical License 2020 - 2026
CO State Medical License 2017 - 2025
TX State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer Start of enrollment: 2006 Apr 01
- Immunotherapy of Patients With Androgen-Independent Prostate Carcinoma Using NY-ESO-1/LAGE1 Peptide Vaccine (SPORE #: 11-01-30-14) Start of enrollment: 2006 Jun 01
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 8 citationsThe habenula as a novel link between the homeostatic and hedonic pathways in cancer-associated weight loss: a pilot study.Maria Maldonado, David L. Molfese, Humsini Viswanath, Kaylah Curtis, Ashley Jones
Journal of Cachexia, Sarcopenia and Muscle. 2018-03-25 - 1 citationsBarriers and Facilitators to the Use of Genomic-Based Targeted Lung Cancer Therapies in the VA: Qualitative Findings.Jennifer Arney, Ashley Helm, Ursula K. Braun, G. John Chen, Teresa G. Hayes
Federal Practitioner. 2018-02-01 - 7 citationsUtilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.Jennifer Arney, Ashley Helm, Travis Crook, Ursula K. Braun, G. John Chen
Lung Cancer. 2018-02-01
Professional Memberships
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
